KinexaTherapeutics ApS
CVR 43952633 · Private limited company (ApS) · Active · Low risk
KinexaTherapeutics ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.9% over the next 12 months, which is 0.6 times the average for Danish companies. 3 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -315k and a net result of DKK -56k. CEO: Mikkel Bender, Lars Jørgensen.
Bankruptcy risk for KinexaTherapeutics ApS
0.6 × the average (1.41%) · higher risk than 70% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 43952633
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (3 years)
- Address
- c/o Symbion, Fruebjergvej 3
2100 København Ø - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Auditor
- Baagøe | Schou, statsautoriseret revisionsaktieselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 1 of 3 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -215.6% |
| Current ratio | 375% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 611 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -130k | DKK -275k |
| Net profit | DKK -56k | DKK -286k |
| Equity | DKK -315k | DKK -259k |
| Total assets | DKK 146k | DKK 67k |
| Cash | DKK 622 | – |
| Short-term debt | DKK 23k | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Baagøe | Schou, statsautoriseret revisionsaktieselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 183 | ||
| 1 Jan 2024 – 31 Dec 2024 | 177 | ||
| 28 Mar 2023 – 31 Dec 2023 | 159 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Mikkel Bender | Current | |
| CEO | Lars Jørgensen | Current | |
| Owner (33%) | MEVA HOLDING ApS | Current | |
| Owner (33%) | CORIS Holding ApS | Current | |
| Owner (33%) | LAJOVI Holding ApS | Current | |
| Founder | MEVA HOLDING ApS | Current | |
| Founder | CORIS Holding ApS | Current | |
| Founder | LAJOVI Holding ApS | Current |
The CEOs' other companies
Mikkel Bender – 8 other companies, of which 1 bankrupt
- Inxo A/S Bankrupt 13 Nov 2025
- Azebiotics ApS Active
- BKG INVESTERING 2014 ApS Fusioneret
- CHAS. HUDE A/S Active
- COPA COPENHAGEN PATENTS KOMPLEMENTAR ApS Active
- COPAseed A/S Active
- MEVA HOLDING ApS Active
- Serpentides ApS Active
Address history (1 moves)
| c/o Symbion, Fruebjergvej 3, 2100 København Ø | |
| c/o Mikkel Bender, Øster Farimagsgade 37, 2100 København Ø |
Other companies at the same address
- A DIMENSION GROUP A/S Bankrupt
- A-SYNTESE BIOTECH ApS Bankrupt
- ABSTRACTION ApS Bankrupt
- ADURA ApS Bankrupt
- AFVIKLINGSSELSKABET AF 8.2.1999 A/S Bankrupt
- ALLEGENETICS DIAGNOSTICS LABORATORY ApS Bankrupt
- ANSARI GROUP S.M.B.A. Bankrupt
- AQUALIFE A/S Bankrupt
- AREA NETWORKS ApS Bankrupt
- ASD Group Denmark ApS Bankrupt
- Afsluttet Projektselskab BLN ApS Bankrupt
- Andersen & Andersen IVS Bankrupt
- Andersentraveller ApS Bankrupt
- ApS VICTORIA STREET KOMPLEMENTAR Bankrupt
- Autocycle International ApS Bankrupt
- BB Ejendomme 2015 IVS Bankrupt
- BB Jyllands investering IVS Bankrupt
- BB Jyllands projekt IVS Bankrupt
- BINCORE GROUP A/S Bankrupt
- BINCORE INDUSTRIES A/S Bankrupt
- BLUSENSE DIAGNOSTICS APS Bankrupt
- BRUUNS INVEST ApS Bankrupt
- BRUUNS REVISION ApS Bankrupt
- BUILD ApS Bankrupt
- Baunsgaard Technologies ApS Bankrupt
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about KinexaTherapeutics ApS
Has KinexaTherapeutics ApS gone bankrupt?
No, KinexaTherapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of KinexaTherapeutics ApS?
Our model estimates a bankruptcy risk of 0.9% over the next 12 months (low risk), which is 0.6 times the average for Danish companies.
Who is the CEO of KinexaTherapeutics ApS?
Mikkel Bender, Lars Jørgensen are the CEOs of KinexaTherapeutics ApS.
Who is the auditor of KinexaTherapeutics ApS?
KinexaTherapeutics ApS most recently used Baagøe | Schou, statsautoriseret revisionsaktieselskab.
When was KinexaTherapeutics ApS founded?
KinexaTherapeutics ApS was founded on 28 March 2023.
What is the equity of KinexaTherapeutics ApS?
Equity was DKK -315k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.